These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 406271)

  • 1. Functional delineation of hyperprolactinemic-amenorrhea.
    Lachelin GC; Abu-fadil S; Yen SS
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1163-74. PubMed ID: 406271
    [No Abstract]   [Full Text] [Related]  

  • 2. Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis.
    Le Roith D; Potashnik G; Glick SM
    Int J Fertil; 1979; 24(2):145-7. PubMed ID: 40911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E; Ranta T; Seppäla M
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sequential pituitary stimulation test in normal subjects and in patients with amenorrhea-galactorrhea with pituitary tumors.
    Kletzky OA; Davajan V; Mishell DR; Nicoloff JT; Mims R; March CM; Nakamura RM
    J Clin Endocrinol Metab; 1977 Oct; 45(4):631-40. PubMed ID: 410820
    [No Abstract]   [Full Text] [Related]  

  • 5. Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors.
    Lamberts SW; Docter R; De Jong FH; Birkenhäger JC; Kwa HG
    Fertil Steril; 1978 Mar; 29(3):287-90. PubMed ID: 346383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
    Rudolf K; Smid I; Kunkel S; Bazsa-Kassai Z
    Zentralbl Gynakol; 1985; 107(14):894-8. PubMed ID: 3929499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts of prolacting physiology in normal and abnormal conditions.
    Archer DF
    Fertil Steril; 1977 Feb; 28(2):125-34. PubMed ID: 401746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactorrhea in sarcoidosis: dynamic studies of prolactin, growth and gonadotropic hormone levels.
    Caro JF; Israel HL; Glennon JA
    Am J Med Sci; 1979; 277(3):289-94. PubMed ID: 110148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
    Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
    J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a silent pituitary somatotropic adenoma based on a paradoxic response of growth hormone on a thyrotropin-releasing hormone or gonadotropin-releasing hormone provocation test.
    Matsuno A; Ogino Y; Katayama H; Osamura RY; Nagashima T
    Am J Obstet Gynecol; 2001 Feb; 184(3):286-8. PubMed ID: 11228475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary hormonal reserve in patients presenting hyperprolactinemia, intrasellar masses, and amenorrhea without galactorrhea.
    Zarate A; Canales ES; Villalobos H; Soria J; Jacobs LS; Kastin AJ; Schally AV
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1034-7. PubMed ID: 805793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G
    Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dopamine in the pathogenesis of normogonadotropic amenorrhea].
    Iumatov TD; Isakov AV; Potin VV; Svechnikova FA
    Probl Endokrinol (Mosk); 1986; 32(4):32-6. PubMed ID: 3093998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic pituitary disorders expressed by galactorrhea. A dynamic evaluation.
    Perez-Lopez FR
    Obstet Gynecol; 1975 Nov; 46(5):621-6. PubMed ID: 812032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 19. [The amenorrhea-galactorrhea syndrome. Clinical and therapeutic aspects of 5 treated cases].
    Nicoletti I; Filipponi P; Nunzi E; Angeletti G; Santeusanio F
    Minerva Med; 1980 Jan; 71(2):89-96. PubMed ID: 7188809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperprolactinemic ovarian insufficiency].
    Rjosk HK; Berg D; von Werder K
    Wien Med Wochenschr; 1984 Sep; 134(17):388-92. PubMed ID: 6437085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.